FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2613530859> ?p ?o ?g. }

• W2613530859 endingPage "1121" @default.
• W2613530859 startingPage "1112" @default.
• W2613530859 abstract "Recent studies indicate the presence of systemic inflammation in psoriatic patients, and this inflammatory status is significantly associated with a range of comorbidities. The aim of this study was to evaluate the clinical significance of novel inflammatory biomarkers, neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and mean platelet volume (MPV) in Japanese patients with plaque-type psoriasis (PsV) and psoriatic arthritis (PsA). One hundred and eighty-six patients with PsV and 50 patients with PsA treated with biologics, including infliximab, adalimumab and ustekinumab, were retrospectively analyzed before and after treatment. At baseline, NLR and PLR, as well as C-reactive protein (CRP), were significantly higher in PsA patients than those in PsV patients, and a significant correlation was found between NLR and PLR. In PsV patients, the NLR-high and PLR-high subgroups exhibited significantly higher Psoriasis Area and Severity Index scores compared with the NLR-low and PLR-low subgroups, respectively, and the NLR-high subgroup also showed higher CRP levels. MPV value was negatively associated with the presence of arthritis, but its association with inflammation was less clear than that of NLR or PLR. After treatment of the patients with biologics for up to 12 months, NLR and PLR decreased promptly in parallel with a decrease of CRP, irrespective of the type of biologics used. Altogether, these results indicate that both NLR and PLR may be useful markers to evaluate systemic inflammation in psoriatic patients. They may serve as simple, convenient and cost-effective biomarkers to monitor the disease course after systemic therapy." @default.
• W2613530859 created "2017-05-19" @default.
• W2613530859 creator A5015950702 @default.
• W2613530859 creator A5022688423 @default.
• W2613530859 creator A5027815875 @default.
• W2613530859 creator A5028511836 @default.
• W2613530859 creator A5035808141 @default.
• W2613530859 creator A5068242406 @default.
• W2613530859 date "2017-05-11" @default.
• W2613530859 modified "2023-10-16" @default.
• W2613530859 title "Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics" @default.
• W2613530859 cites W1526387844 @default.
• W2613530859 cites W1543621601 @default.
• W2613530859 cites W1828616852 @default.
• W2613530859 cites W1972390741 @default.
• W2613530859 cites W1978855446 @default.
• W2613530859 cites W1982012733 @default.
• W2613530859 cites W1988968382 @default.
• W2613530859 cites W1995757985 @default.
• W2613530859 cites W2009821632 @default.
• W2613530859 cites W2048758257 @default.
• W2613530859 cites W2050451014 @default.
• W2613530859 cites W2052783235 @default.
• W2613530859 cites W2068089617 @default.
• W2613530859 cites W2076350919 @default.
• W2613530859 cites W2076756771 @default.
• W2613530859 cites W2078589140 @default.
• W2613530859 cites W2080172852 @default.
• W2613530859 cites W2112639571 @default.
• W2613530859 cites W2124456033 @default.
• W2613530859 cites W2136747946 @default.
• W2613530859 cites W2140033718 @default.
• W2613530859 cites W2145390384 @default.
• W2613530859 cites W2147121896 @default.
• W2613530859 cites W2157432727 @default.
• W2613530859 cites W2180588657 @default.
• W2613530859 cites W2183783980 @default.
• W2613530859 cites W2235471063 @default.
• W2613530859 cites W2340288216 @default.
• W2613530859 cites W2916688159 @default.
• W2613530859 cites W4211077900 @default.
• W2613530859 doi "https://doi.org/10.1111/1346-8138.13875" @default.
• W2613530859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28493493" @default.
• W2613530859 hasPublicationYear "2017" @default.
• W2613530859 type Work @default.
• W2613530859 sameAs 2613530859 @default.
• W2613530859 citedByCount "60" @default.
• W2613530859 countsByYear W26135308592017 @default.
• W2613530859 countsByYear W26135308592018 @default.
• W2613530859 countsByYear W26135308592019 @default.
• W2613530859 countsByYear W26135308592020 @default.
• W2613530859 countsByYear W26135308592021 @default.
• W2613530859 countsByYear W26135308592022 @default.
• W2613530859 countsByYear W26135308592023 @default.
• W2613530859 crossrefType "journal-article" @default.
• W2613530859 hasAuthorship W2613530859A5015950702 @default.
• W2613530859 hasAuthorship W2613530859A5022688423 @default.
• W2613530859 hasAuthorship W2613530859A5027815875 @default.
• W2613530859 hasAuthorship W2613530859A5028511836 @default.
• W2613530859 hasAuthorship W2613530859A5035808141 @default.
• W2613530859 hasAuthorship W2613530859A5068242406 @default.
• W2613530859 hasConcept C126322002 @default.
• W2613530859 hasConcept C190481736 @default.
• W2613530859 hasConcept C203014093 @default.
• W2613530859 hasConcept C2776252253 @default.
• W2613530859 hasConcept C2776260265 @default.
• W2613530859 hasConcept C2776914184 @default.
• W2613530859 hasConcept C2777011040 @default.
• W2613530859 hasConcept C2777077863 @default.
• W2613530859 hasConcept C2777138892 @default.
• W2613530859 hasConcept C2777575956 @default.
• W2613530859 hasConcept C2777761686 @default.
• W2613530859 hasConcept C2778963024 @default.
• W2613530859 hasConcept C2778975655 @default.
• W2613530859 hasConcept C2779134260 @default.
• W2613530859 hasConcept C2779786854 @default.
• W2613530859 hasConcept C2780132546 @default.
• W2613530859 hasConcept C2780564577 @default.
• W2613530859 hasConcept C63363279 @default.
• W2613530859 hasConcept C71924100 @default.
• W2613530859 hasConcept C89560881 @default.
• W2613530859 hasConcept C90924648 @default.
• W2613530859 hasConceptScore W2613530859C126322002 @default.
• W2613530859 hasConceptScore W2613530859C190481736 @default.
• W2613530859 hasConceptScore W2613530859C203014093 @default.
• W2613530859 hasConceptScore W2613530859C2776252253 @default.
• W2613530859 hasConceptScore W2613530859C2776260265 @default.
• W2613530859 hasConceptScore W2613530859C2776914184 @default.
• W2613530859 hasConceptScore W2613530859C2777011040 @default.
• W2613530859 hasConceptScore W2613530859C2777077863 @default.
• W2613530859 hasConceptScore W2613530859C2777138892 @default.
• W2613530859 hasConceptScore W2613530859C2777575956 @default.
• W2613530859 hasConceptScore W2613530859C2777761686 @default.
• W2613530859 hasConceptScore W2613530859C2778963024 @default.
• W2613530859 hasConceptScore W2613530859C2778975655 @default.
• W2613530859 hasConceptScore W2613530859C2779134260 @default.
• W2613530859 hasConceptScore W2613530859C2779786854 @default.
• W2613530859 hasConceptScore W2613530859C2780132546 @default.

• next